Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Cash from Investing Activities (2016 - 2025)

CytomX Therapeutics' Cash from Investing Activities history spans 12 years, with the latest figure at -$14.4 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 195.27% year-over-year to -$14.4 million; the TTM value through Dec 2025 reached -$59.7 million, down 159.92%, while the annual FY2025 figure was -$59.7 million, 159.92% down from the prior year.
  • Cash from Investing Activities reached -$14.4 million in Q4 2025 per CTMX's latest filing, down from $439000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $99.8 million in Q4 2022 to a low of -$146.6 million in Q1 2023.
  • Average Cash from Investing Activities over 5 years is $501550.0, with a median of $5.1 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: surged 40842.04% in 2022, then plummeted 19824.18% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$245000.0 in 2021, then soared by 40842.04% to $99.8 million in 2022, then tumbled by 87.11% to $12.9 million in 2023, then rose by 17.64% to $15.1 million in 2024, then tumbled by 195.27% to -$14.4 million in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Cash from Investing Activities are -$14.4 million (Q4 2025), $439000.0 (Q3 2025), and -$76.4 million (Q2 2025).